Bellwether Investment Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,004
Closed -$67K 435
2017
Q1
$67K Buy
1,004
+88
+10% +$5.86K 0.18% 116
2016
Q4
$60K Buy
+916
New +$59.4K 0.05% 248
2016
Q2
$9K Buy
+126
New +$8.71K 0.01% 423

Other funds holding NVS

Bellwether Investment Group's NVS Position: Q2 2017 in Review

Bellwether Investment Group sold out of Novartis (NVS) in Q2 2017, closing a stake of 1,004 shares — an estimated $67K sold.

Bellwether Investment Group first reported a position in NVS in Q2 2016 and held it in 3 quarters. The position peaked at $67K in Q1 2017. 920 funds tracked by Wall St. Rank hold NVS as of Q2 2017.

  • Bellwether Investment Group reported no remaining Novartis position as of Q2 2017 after selling out during the quarter.
  • Bellwether Investment Group sold 1,004 Novartis shares in Q2 2017, an estimated $67K.
  • Bellwether Investment Group first reported a position in Novartis in Q2 2016 and held it in 3 quarters.
  • Bellwether Investment Group's Novartis position peaked at $67K in Q1 2017.
  • 920 funds tracked by Wall St. Rank held Novartis as of Q2 2017.

Based on Bellwether Investment Group's 13F filing for Q2 2017, filed 8 Aug 2017.